s6y

CNBX Pharmaceuticals Inc.

Ticker
CNBX
CIK
1343009
Industry
Pharmaceutical Preparations
Formerly
Cannabics Pharmaceuticals Inc., American Mining Corp, Thrust Energy Corp.

Financials 97

  1. 10-Q Quarterly Report for period ending May 31, 2026
  2. 10-Q Quarterly Report for period ending Feb 28, 2026
  3. 10-Q Quarterly Report for period ending Nov 30, 2025
  4. 10-K Annual Report for period ending Aug 31, 2025
  5. 10-Q Quarterly Report for period ending May 31, 2025
  6. 10-Q Quarterly Report for period ending Feb 28, 2025
  7. 10-Q Quarterly Report for period ending Nov 30, 2024
  8. 10-K Annual Report for period ending Aug 31, 2024
  9. 10-Q Quarterly Report for period ending May 31, 2024
  10. 10-Q Quarterly Report for period ending Feb 29, 2024

All 97 financials filings

News 82

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 82 news filings

Ownership 30

  1. SC 13G/A Major Shareholders
  2. SC 13G/A Major Shareholders
  3. SC 13G Major Shareholders
  4. SC 13G Major Shareholders
  5. 3 Initial statement of beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. SC 13D/A Major Shareholders
  9. 4 Statement of changes in beneficial ownership of securities
  10. SC 13D Major Shareholders

All 30 ownership filings

Prospectus 18

  1. RW Registration Withdrawal Request
  2. S-1 General form of registration statement for all companies including face-amount certificate companies
  3. S-1 General form of registration statement for all companies including face-amount certificate companies
  4. S-1/A General form of registration statement for all companies including face-amount certificate companies
  5. S-1 General form of registration statement for all companies including face-amount certificate companies
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. 424B2 Prospectus filed pursuant to Rule 424(b)(2)
  8. 424B2 Prospectus filed pursuant to Rule 424(b)(2)
  9. 424B2 Prospectus filed pursuant to Rule 424(b)(2)
  10. 424B2 Prospectus filed pursuant to Rule 424(b)(2)

All 18 prospectus filings

Proxies 4

  1. DEF 14C Definitive information statements
  2. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  3. DEF 14C Definitive information statements
  4. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition

Other 71

  1. SCHEDULE 13G/A
  2. SCHEDULE 13G/A
  3. SCHEDULE 13G/A
  4. SCHEDULE 13G/A
  5. SCHEDULE 13G/A
  6. SCHEDULE 13G/A
  7. SCHEDULE 13G/A
  8. SCHEDULE 13G/A
  9. UPLOAD Letter (PDF)
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 71 other filings